Lensar (LNSR) EBT (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 145.52% |
| Dec 31, 2025 | 35.11% |
| Sep 30, 2025 | -20.53% |
| Jun 30, 2025 | -8.62% |
| Mar 31, 2025 | -348.84% |
| Dec 31, 2024 | -3.61% |
| Sep 30, 2024 | 76.42% |
| Jun 30, 2024 | -85.26% |
| Mar 31, 2024 | 3.75% |
| Dec 31, 2023 | -45.15% |
| Sep 30, 2023 | 28.85% |
| Jun 30, 2023 | 34.26% |
| Mar 31, 2023 | -66.90% |
| Dec 31, 2022 | 36.00% |
| Sep 30, 2022 | 39.94% |
| Jun 30, 2022 | -1.72% |
| Mar 31, 2022 | -70.83% |
| Dec 31, 2021 | 36.55% |
| Sep 30, 2021 | -40.91% |
| Jun 30, 2021 | 15.87% |
| Mar 31, 2021 | 24.07% |
| Dec 31, 2020 | -43.35% |
| Sep 30, 2020 | -5.83% |
| Jun 30, 2020 | -21.90% |
| Mar 31, 2020 | -49.01% |
| Dec 31, 2019 | 57.38% |